Fund profile / United States

Cantos Fund IV

Geography: United States
Stage: Pre-Seed
Fund size: $70M
Focus: Biotech, Deep Tech, Defense and Manufacturing
Signals: Published

N°01 / About

About Cantos Fund IV

Cantos Fund IV is a $70M oversubscribed pre-seed and seed vehicle led by founder and GP Ian Rountree, closed in early 2026. Intentionally sized below Fund III's capacity to preserve meaningful ownership, the fund backs near-frontier deep tech across aerospace/defense, nuclear, biotech, advanced manufacturing, and compute, targeting roughly 22 investments with $1.5M-4M checks through 2026-2027. Portfolio includes Neros, Castelion, Heaviside, Astranis, Skyryse, and Venus Aerospace.

N°02 / Thesis

Investment Focus

Location / RegionUnited States

Funding StagePre-Seed

Industry Focus

Biotech

Deep Tech

Defense

Manufacturing

Space

Investor Signals Profile

active

Sweet Spot

Deep-tech founders building focused single-product companies in aerospace, nuclear, biotech

defense-tech

deep-tech

space

nuclear

advanced-manufacturing

Bullish Signals

Fund IV oversubscribed at $70M despite smaller sizeweb

Portfolio includes category leaders Neros, Castelion, Astranis, Skyryseweb

Concentrated ~22-company strategy preserves ownership and follow-on firepowerweb

Contrarian Signals

Narrow defense/deep-tech thesis excludes founders outside verticalsweb

Concentrated portfolio means higher bar and fewer bets per cycleweb

Founder Do's

Lead with single, laser-focused product not broad platform

Show credible path to defense or dual-use government contracts

Target check sizes $1.5M–4M for pre-seed or seed

Founder Don'ts

No broad horizontal software without deep-tech or hardware edge

Don't expect more than ~22 portfolio slots — bar is high

11 signals on Cantos Fund IV

3 bullish · 2 contrarian · 3 pitch do's · 2 don'ts · 1 GP profile, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size$70M

Saves0

Website

People

Key People

Ian Rountree

Ian RountreeFounder / General Partner

N°04 / See also

Related Funds

Asymmetric Capital Partners Fund II

Fund size$137M

Location: United States
Stage: Pre Seed
Focus: Vertical Saas, Digital Health, Saas
Manager: Rob Biederman, Nancy Chou, Sam Clayman

Pre Seed

Vertical Saas

Digital Health

Saas

Bain Capital Life Sciences IV

Fund size$3000M

Location: United States
Stage: Seed
Focus: Biotech, Saas
Manager: Matthew Calistri, Allyson Rinderle

Seed

Biotech

Saas

eGateway Capital II

Fund size$94M

Location: United States
Stage: Series A
Focus: Ai Ml, Ecommerce
Manager: Chad Summe

Series A

Ai Ml

Ecommerce